Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Rank in Stocks #20651
Nuformix plc operates in the field of pharmaceutical development for treating... Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Share Price
$0.00244926
Market Cap
$51.67K
Change (1 day)
5.88%
Change (1 year)
110.15%
Country
GB
Trade Nuformix plc (NFX)

Category

Price of NFX with the market cap of B
Nuformix plc Nuformix plc
NFX
$0.00244926
Market Capitalization of Nuformix plc(NFX)
Market Cap: $51.67K
As of March 2026 Nuformix plc has a market cap of $51.67K. This makes Nuformix plc the world's 20651st most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Nuformix plc from 2015 to 2026
NFX compared with Top 5 Most Popular stocks
Price of NFX Asset B Mkt. of B Results
Nuformix plc Nuformix plc
$193,530 $51.67K
$4.083T +7,901,557,288.79%
Nuformix plc Nuformix plc
$174,048 $51.67K
$3.672T +7,106,147,873.66%
Nuformix plc Nuformix plc
$157,790 $51.67K
$3.329T +6,442,344,452.04%
Nuformix plc Nuformix plc
$126,216 $51.67K
$2.663T +5,153,223,933.04%
Nuformix plc Nuformix plc
$102,047 $51.67K
$2.153T +4,166,447,817.23%